Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mealey's is a premier provider of legal news and analysis, specializing in litigation reports that are critical to the pharmaceutical, medical device, and insurance industries. Founded in 1984 and later acquired by LexisNexis, the company is best known for its "Mealey's Litigation Reports," which provide detailed coverage of high-stakes legal battles, including toxic torts, asbestos, and drug-related product liability. For life science analysts, Mealey's serves as a vital resource for tracking the legal risks, court rulings, and settlement trends affecting major healthcare companies and their product pipelines. The service offers specialized reports such as the Mealey's Litigation Report: Drugs and Medical Devices, which monitors litigation involving FDA-approved substances and medical technologies. By providing expert commentary and primary legal documents, Mealey's helps industry professionals navigate the complex intersection of law, medicine, and corporate liability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mealey's.